Abstract
Background: Environmental factors such as air pollution have been associated with Parkinson's disease (PD), but findings have been inconsistent. We investigated the association between exposure to several air pollutants, road traffic noise, and PD risk in two Dutch cohorts. Methods: Data from 50,087 participants from two Dutch population-based cohort studies, European Prospective Investigation into Cancer and Nutrition in the Netherlands and Arbeid, Milieu en Gezondheid Onderzoek were analyzed. In these cohorts, 235 PD cases were ascertained based on a previously validated algorithm combining self-reported information (diagnosis, medication, and symptoms) and registry data. We assigned the following traffic-related exposures to residential addresses at baseline: NO2,NOx, particulate matter (PM)2.5absorbance(as a marker for black carbon exposure), PM with aerodynamic diameter ≤2.5 m (PM2.5), ≤10 m (PM10), PMcoarse(size fraction 2.5-10 m), ultrafine particles <0.1 m (UFP), and road traffic noise (Lden). Logistic regression models were applied to investigate the associations with PD, adjusted for possible confounders. Results: Both single-and two-pollutant models indicated associations between exposure to NOx, road traffic noise, and increasing odds of developing PD. Odds ratios of fully adjusted two-pollutant models in the highest compared with the lowest exposure quartile were 1.62 (95% CI = 1.02, 2.62) for NOxand 1.47 (95% CI = 0.97, 2.25) for road traffic noise, with clear trends across exposure categories. Conclusions: Our findings suggest that NOxand road traffic noise are associated with an increased risk of PD. While the association with NOxhas been shown before, further investigation into the possible role of environmental noise on PD is warranted.
Original language | English |
---|---|
Article number | E272 |
Number of pages | 7 |
Journal | Environmental Epidemiology |
Volume | 7 |
Issue number | 6 |
DOIs | |
Publication status | Published - Dec 2023 |
Bibliographical note
Publisher Copyright:© 2023 Wolters Kluwer Health. All rights reserved.
Funding
The project received funding from EXPOSOME-NL (NWO; project number 024.004.017), EXPANSE (EU-H2020 Grant number 874627) and by the Netherlands Organisation for Health Research and Development (ZonMw) within the Electromagnetic Fields and Health Research programme (grant numbers 85200001 and 85500003). The EPIC-NL study was funded by the Dutch Ministry of Health, Welfare and Sports (VWS); the Dutch ZonMw (Dutch Prevention funds); the World Cancer Research Fund (WCRF); Dutch Cancer Society (KWF); Julius Center; University Medical Center Utrecht and the National Institute for Public Health and the Environment (RIVM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Funders | Funder number |
---|---|
Dutch ZonMw | |
EU-H2020 | 874627 |
EXPANSE | |
HELIX The Human Early-Life Exposome project | |
Julius Center | |
Centre for Health Protection, National Institute for Public Health and the Environment, Bilthoven, The Netherlands. | |
University Medical Center Utrecht | |
World Cancer Research Fund International | |
ZonMw | 85200001, 85500003 |
Ministerie van Volksgezondheid, Welzijn en Sport | |
Nederlandse Organisatie voor Wetenschappelijk Onderzoek | 024.004.017 |
KWF Kankerbestrijding | |
Rijksinstituut voor Volksgezondheid en Milieu (RIVM) |